Trends in ACEi and ARB expenditure: Compelling case for competition in generic drug markets
- PMID: 36414045
- DOI: 10.1016/j.ijcard.2022.11.027
Trends in ACEi and ARB expenditure: Compelling case for competition in generic drug markets
Conflict of interest statement
Declaration of Competing Interest The authors (JB and MH) report no relationships that could be construed as a conflict of interest.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources